DermTech, Inc. Common Stock
DMTK
DMTK was delisted on the 26th of June, 2024.
12 hedge funds and large institutions have $62.1M invested in DermTech, Inc. Common Stock in 2017 Q3 according to their latest regulatory filings, with 12 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FTCM
Fir Tree Capital Management
New York
|
+$12.2M |
| 2 |
PAMP
Polar Asset Management Partners
Toronto,
Ontario, Canada
|
+$10.1M |
| 3 |
HIM
HGC Investment Management
Toronto,
Ontario, Canada
|
+$9.4M |
| 4 |
AA
AQR Arbitrage
Greenwich,
Connecticut
|
+$6.81M |
| 5 |
KPF
K2 Principal Fund
Toronto,
Ontario, Canada
|
+$6.47M |
Top Sellers
DMTK Hedge Fund Activity: Q3 2017 in Review
12 of the 4,022 institutional investors tracked by Wall St. Rank reported a position in DermTech, Inc. Common Stock (DMTK) for Q3 2017, worth a combined $62.1M.
Buyers outnumbered sellers: 12 funds opened new DMTK positions and 0 closed out — a net gain of 12 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Fir Tree Capital Management, opening a new position worth an estimated $12.2M.
- 12 institutional investors held DermTech, Inc. Common Stock (DMTK) as of Q3 2017, up from 0 in Q2 2017.
- Funds reported $62.1M of DermTech, Inc. Common Stock stock for Q3 2017.
- 12 funds opened new DermTech, Inc. Common Stock positions in Q3 2017 and 0 closed out, a net change of +12 holders.
- The largest DermTech, Inc. Common Stock buyer in Q3 2017 was Fir Tree Capital Management, an estimated $12.2M added.
Based on aggregated 13F filings for Q3 2017.